Santori & Peters Inc’s Edwards Lifesciences EW Stock Holding History

Santori & Peters Inc’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-576	Closed	-$24K	–	219
2017 Q4	$24K	Buy	+576	New	+$21.1K	0.02%	172

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Santori & Peters Inc's EW Position: Q1 2018 in Review

Santori & Peters Inc sold out of Edwards Lifesciences (EW) in Q1 2018, closing a stake of 576 shares — an estimated $24K sold.

Santori & Peters Inc first reported a position in EW in Q4 2017 and held it in 1 quarter. The position peaked at $24K in Q4 2017. 815 funds tracked by Wall St. Rank hold EW as of Q1 2018.

Santori & Peters Inc reported no remaining Edwards Lifesciences position as of Q1 2018 after selling out during the quarter.
Santori & Peters Inc sold 576 Edwards Lifesciences shares in Q1 2018, an estimated $24K.
Santori & Peters Inc first reported a position in Edwards Lifesciences in Q4 2017 and held it in 1 quarter.
Santori & Peters Inc's Edwards Lifesciences position peaked at $24K in Q4 2017.
815 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2018.

Based on Santori & Peters Inc's 13F filing for Q1 2018, filed 16 Apr 2018.